| Id |
Subject |
Object |
Predicate |
Lexical cue |
| SS1_24929890_2_0 |
278-309 |
expanded |
denotes |
clear cell renal cell carcinoma |
| SS2_24929890_2_0 |
311-316 |
abbr |
denotes |
ccRCC |
| SS1_24929890_6_0 |
521-547 |
expanded |
denotes |
MNNG HOS transforming gene |
| SS2_24929890_6_0 |
549-552 |
abbr |
denotes |
MET |
| SS1_24929890_6_1 |
693-727 |
expanded |
denotes |
vascular endothelial growth factor |
| SS2_24929890_6_1 |
729-733 |
abbr |
denotes |
VEGF |
| SS1_24929890_6_2 |
738-767 |
expanded |
denotes |
mammalian target of rapamycin |
| SS2_24929890_6_2 |
769-773 |
abbr |
denotes |
mTOR |
| AE1_24929890_2_0 |
SS1_24929890_2_0 |
SS2_24929890_2_0 |
abbreviatedTo |
clear cell renal cell carcinoma,ccRCC |
| AE1_24929890_6_0 |
SS1_24929890_6_0 |
SS2_24929890_6_0 |
abbreviatedTo |
MNNG HOS transforming gene,MET |
| AE1_24929890_6_1 |
SS1_24929890_6_1 |
SS2_24929890_6_1 |
abbreviatedTo |
vascular endothelial growth factor,VEGF |
| AE1_24929890_6_2 |
SS1_24929890_6_2 |
SS2_24929890_6_2 |
abbreviatedTo |
mammalian target of rapamycin,mTOR |
